A phase I study of INCA034460 for Vitiligo
Latest Information Update: 08 Nov 2023
At a glance
- Drugs Auremolimab (Primary)
- Indications Vitiligo
- Focus Adverse reactions
Most Recent Events
- 08 Nov 2023 New trial record
Latest Information Update: 08 Nov 2023